Capdevila J, Klochikhin A, Leboulleux S, Isaev P, et al. A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer. Thyroid 2022 Apr 10. doi: 10.1089/thy.2022.0027.
PMID: 35403447